AI assistant
CELTIC PLC — Share Issue/Capital Change 2014
Sep 3, 2014
7553_rns_2014-09-03_8b6687c3-0325-4a47-b016-5cf9f455ba51.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7004Q
Celtic PLC
03 September 2014
CELTIC PLC
Issued share capital
As a result of the issue on 1 September 2014 of 58,547 Ordinary Shares of 1p each ("Ordinary Shares") under the Company's scrip dividend reinvestment scheme, Celtic PLC's issued share capital as at 1 September 2014 was as follows:
92,745,701 Ordinary Shares of 1p each
13,203,949 Cumulative Convertible Preferred Ordinary Shares of 100p each
16,175,097 Cumulative Convertible Preference Shares of 60 p each
608,017,505 Deferred Shares of 1p each
Cumulative Convertible Preference Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights.
The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure and Transparency Rules.
The new Ordinary Shares of 1p each allotted under the scrip scheme have been issued at a notional price of 74.5p each.
Application has been made for the admission of the 58,547 new Ordinary Shares of 1p each ("New Ordinary Shares") to trading on AIM. It is expected that the New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, will be admitted to trading on 09 September 2014.
Enquiries:
Company
Michael Nicholson, Company Secretary 0141 551 4298
Canaccord Genuity Limited
Bruce Garrow, Nominated Adviser 020 7523 8350
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEZXLBBZKFEBBX